Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (111-120 of 185) with videos related to

Pageof 19
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul Muntner, Barry R Davis, William C Cushman, et al.
British Journal of Haematology|November 3, 2015
Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trialJohn C Wood, Alan R Cohen, Sara L Pressel, et al.
Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
Circulation|November 13, 2008
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trialBarry R Davis, John B Kostis, Lara M Simpson, et al.
The American Journal of Medicine|December 17, 2016
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHATSripal Bangalore, Barry R Davis, William C Cushman, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
American Heart Journal|August 17, 2004
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement TrialSatish Kenchaiah, Barry R Davis, Eugene Braunwald, et al.
Hypertension (Dallas, Tex. : 1979)|March 27, 2013
Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sexSuzanne Oparil, Barry R Davis, William C Cushman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pageof 19

Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Paul Muntner, Barry R Davis, William C Cushman, et al.
British Journal of Haematology|November 3, 2015
Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trialJohn C Wood, Alan R Cohen, Sara L Pressel, et al.
Nature Medicine|July 1, 2026
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trialsQianqian Yang, Zeinab Bidel, Dexter Canoy, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
Circulation|November 13, 2008
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trialBarry R Davis, John B Kostis, Lara M Simpson, et al.
The American Journal of Medicine|December 17, 2016
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHATSripal Bangalore, Barry R Davis, William C Cushman, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
American Heart Journal|August 17, 2004
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement TrialSatish Kenchaiah, Barry R Davis, Eugene Braunwald, et al.
Hypertension (Dallas, Tex. : 1979)|March 27, 2013
Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sexSuzanne Oparil, Barry R Davis, William C Cushman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Pageof 19